Aurion Biotech, Inc. (AURN)
Aurion Biotech will go public soon, but the exact IPO date is still unknown.
Stock Price: Pending
IPO price not available yet

Aurion Biotech Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec '23 Dec '22
Cash & Equivalents
52.0741.3518.87
Cash & Cash Equivalents
52.0741.3518.87
Cash Growth
-119.18%-
Other Current Assets
1.060.550.39
Total Current Assets
54.5741.919.25
Property, Plant & Equipment
-3.162.49
Goodwill and Intangibles
-6.497.56
Other Long-Term Assets
-1.061.03
Total Long-Term Assets
-10.7111.07
Total Assets
-52.6130.32
Accounts Payable
-0.851.01
Current Debt
-1.240.98
Other Current Liabilities
14.97.147.3
Total Current Liabilities
14.99.229.29
Long-Term Debt
-5.456.73
Total Long-Term Liabilities
-5.456.73
Total Liabilities
-14.6816.02
Total Debt
62.556.697.71
Debt Growth
--13.22%-
Retained Earnings
--157.85-112.3
Comprehensive Income
--1.49-1.43
Shareholders' Equity
-220.54-176.85-135.47
Net Cash / Debt
-10.4934.6611.16
Net Cash / Debt Growth
-210.65%-
Working Capital
39.6732.689.96
Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).